Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Price to Book (2024 - 2026)

Updated

Impact Biomedical's (IBO) Price to Book stood at 3.54 in Q2 2026, down 19.5% from the prior quarter.

Analysis

Impact Biomedical (IBO) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Impact Biomedical's Price to Book came in at 1.01, down 56.0% from FY2024.

  • Across earlier years, Price to Book came in at 2.30 in FY2024.
  • Quarterly Price to Book has ranged from 0.67 in Q3 2024 to 4.40 in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,142.35 Bn 1,110.94 Bn 19.71 Bn
2 Johnson & Johnson 635.52 Bn 555.38 Bn 17.30 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 356.35 Bn 310.72 Bn 12.21 Bn
5 Novartis Ag 300.53 Bn 264.52 Bn 11.24 Bn
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn
7 Amgen 238.00 Bn 193.40 Bn 7.24 Bn
8 Gilead Sciences 194.35 Bn 168.55 Bn 6.22 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn
10 Impact Biomedical 397.86 Mn 397.82 Mn 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.54
Mar 31, 2026 4.40
Dec 31, 2025 1.01
Mar 31, 2025 1.54
Dec 31, 2024 2.30
Sep 30, 2024 0.67
API Access

Impact Biomedical Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=IBO&period=max&api_key=YOUR_API_KEY